Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04292535 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
A Phase 2 study of Exercise and Insulin, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT04292535 is a Phase 2 study of Exercise and Insulin that has completed, run by Michigan State University. The registered enrollment target is 116 participants, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04292535, a Phase 2 study of Exercise and Insulin, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if physical activity engagement alters the dose-response profile and safety of administration of insulin into the intranasal mucosa.
Interventions
- DRUG Placebo into the intranasal mucosa
- DRUG 20 IU NovoLog Insulin aspart into the intranasal mucosa
- DRUG 40 IU NovoLog Insulin aspart into the intranasal mucosa
- DRUG 60 IU NovoLog Insulin aspart into the intranasal mucosa
- DRUG 80 IU NovoLog Insulin aspart into the intranasal mucosa
Study Locations (1)
Michigan
- Department of Kinesiology - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2020-02-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04292535
The ClinicalTrials.gov registry entry for NCT04292535 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 5 interventions - of which Placebo into the intranasal mucosa is the first listed.
NCT04292535 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04292535 about?
NCT04292535 is a clinical study titled "Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise". To determine if physical activity engagement alters the dose-response profile and safety of administration of insulin into the intranasal mucosa.
What is the current status of trial NCT04292535?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2018-06-15. Estimated completion is 2020-02-20.
What conditions does trial NCT04292535 study?
This clinical trial studies the following conditions: Exercise, Insulin.
What interventions are being tested in trial NCT04292535?
The interventions under investigation include: Placebo into the intranasal mucosa (DRUG), 20 IU NovoLog Insulin aspart into the intranasal mucosa (DRUG), 40 IU NovoLog Insulin aspart into the intranasal mucosa (DRUG), 60 IU NovoLog Insulin aspart into the intranasal mucosa (DRUG), 80 IU NovoLog Insulin aspart into the intranasal mucosa (DRUG).
Who is sponsoring clinical trial NCT04292535?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04292535 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Response to Exercise and Nitric Oxide in PAD
RECRUITING · Phase 2
-
Fasted vs. Fed State Exercise
RECRUITING · Phase 2
-
Vasodilator and Exercise Study for DMD (VASO-REx)
RECRUITING · Phase 2
-
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
RECRUITING · Phase 2
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.